Supporting treatment decision-making for patients with multiple myeloma post-DRd in Italy: a multi-criteria decision framework

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Network Meta-Analysis of Randomized Trials in Relapsed/Refractory Multiple Myeloma: Relative Efficacy for Patients Who Are Lenalidomide-Refractory2023 · 2 citations
2. 2Medicine price transparency and confidential managed-entry agreements in Europe: findings from the EURIPID survey2021 · 26 citations
3. 3A patient survey indicates quality of life and progression-free survival as equally important outcome measures in multiple myeloma clinical trials2023 · 8 citations
4. 4Rising Unmet Need in Multiple Myeloma Management After First-Line Treatment With DRd: Expected Epidemiological Evolution in Italy2025 · 1 citations
5. 5Impact of Treatment Sequencing on Overall Survival in Patients with Transplant-Ineligible Newly Diagnosed Myeloma2023 · 28 citations